Helicobacter spp. infections in chronic liver damage

被引:0
|
作者
Rybicka, Magda [1 ]
Stalke, Piotr [2 ]
Bielawski, Krzysztof Piotr [1 ]
Nakonieczna, Joanna [1 ]
机构
[1] Uniwersytetu Med, Uniwersytetu Gdanskiego & Gdanskiego, Katedra Biotechnol, Miedzyuczelniany Wydzial Biotechnol, Gdansk, Poland
[2] Gdanski Uniwersytet Med, Klin Chorob Zakaznych, Gdansk, Poland
关键词
Helicobacter spp; Helicobacter pylori; hepatocellular carcinoma; chronic liver diseases; CHRONIC ACTIVE HEPATITIS; HEPATOCELLULAR-CARCINOMA; PYLORI INFECTION; SP-NOV; CHRONIC CHOLECYSTITIS; MICE; DISEASE; CIRRHOSIS; BILE; CHILDREN;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Liver is a key organ responsible for organism's homeostasis. A proper function of this organ is crucial for detoxification of metabolic products and regulation of metabolic processes of macromolecules (proteins, lipids, carbohydrates). The most important infectious factors, leading to liver damage, are primary hepatotropic viruses, particularly those causing chronic inflammation of the organ (HBV, HCV, HDV), which may subsequently cause cirrhosis and/or primary hepatocellular carcinoma. There has been a growing interest in Helicobacter spp. liver infections as a potential factor promoting injury of the organ towards hepatocellular carcinoma. The association between hepatocellular carcinoma and the presence of Helicobacters in the liver has been well documented in animal models (Helicobacter hepaticus versus liver cancer in mice). Some reports also indicate similar association in humans, where the presence of Helicobacter antigens in patients with liver cancer is detected more often in comparison to healthy or chronically infected population. Although the molecular mechanisms underlying such a phenomenon are not well known, the knowledge on this subject has considerably increased during recent years. The review presents data on the association between the presence of Helicobacter spp. in the liver and injuries of the organ, as well as the role that is played by the bacteria in chronic liver diseases.
引用
收藏
页码:386 / 395
页数:10
相关论文
共 50 条
  • [21] Helicobacter spp. found in gallbladder stones
    Govorun, VM
    Momynaliev, KT
    Chelisheva, VV
    Isakov, VA
    [J]. GUT, 2002, 51 : A74 - A74
  • [22] Helicobacter spp. in gastroscopic biopsies in dogs
    Krstic, V
    Marinkovic, D.
    Vakanjac, Slobodanka
    Lalosevic, D.
    Aleksic-Kovacevic, Sanja
    [J]. ACTA VETERINARIA-BEOGRAD, 2006, 56 (04): : 305 - 314
  • [23] Helicobacter spp. and gastrointestinal diseases in animals
    DeGroote, D
    Haesebrouck, F
    Ducatelle, R
    Devriese, L
    [J]. VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT, 1997, 66 (01): : 8 - 13
  • [24] Motility of Different Gastric Helicobacter spp.
    Bansil, Rama
    Constantino, Maira A.
    Su-Arcaro, Clover
    Liao, Wentian
    Shen, Zeli
    Fox, James G.
    [J]. MICROORGANISMS, 2023, 11 (03)
  • [25] Detection of Helicobacter spp. DNA in hepatic tissue of patients with chronic hepatitis C
    Petrenkiene, Vitalija
    Jonaitis, Laimas
    Kupcinskas, Limas
    Vitkauskiene, Astra
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A207 - A207
  • [26] Helicobacter spp. in Experimental Models of Colitis
    Mueller, Christoph
    Chung, Cheong K. C. Kwong
    Faderl, Martin R.
    Brasseit, Jennifer
    Zysset, Daniel
    [J]. ORAL MUCOSAL IMMUNITY AND MICROBIOME, 2019, 1197 : 97 - 105
  • [27] Prevalence of cagA and vacA in Helicobacter spp.
    Fauconnier, A
    Bollen, A
    Lage, AP
    [J]. GUT, 1997, 41 : A123 - A124
  • [28] Sarcocystis spp. in human infections
    Fayer, R
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2004, 17 (04) : 894 - +
  • [29] Treatment of Acinetobacter spp. infections
    Levin, AS
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (08) : 1289 - 1296
  • [30] Bartonella spp. Infections, Thailand
    Bhengsri, Saithip
    Baggett, Henry C.
    Peruski, Leonard F., Jr.
    Morway, Christina
    Bai, Ying
    Fisk, Tamara L.
    Sitdhirasdr, Anussorn
    Maloney, Susan A.
    Dowell, Scott F.
    Kosoy, Michael
    [J]. EMERGING INFECTIOUS DISEASES, 2010, 16 (04) : 743 - 745